Panacea Biotec Limited has informed the Exchange regarding a press release dated Jun 08, 2026, titled "Launch of the DENSTAR project: advancing the licensure of a tetravalent liveattenuateddengue vaccine (DengiAll®) in sub-Saharan Africa and to facilitate its global access".
Press Release Jun 08 2026
Earlier from Panacea Biotec
- Panacea Biotec: Unaudited Financial Results for quarter and nine months ended December 31, 2025
- Panacea Biotec: Annual Return for financial year 2024-25
- Panacea Biotec: Unaudited financial results for quarter and half year ended September 30, 2025
- Press Release Sep 24 2025